Related Experiment Video

Updated: May 24, 2026

Surgical Swine Model of Chronic Cardiac Ischemia Treated by Off-Pump Coronary Artery Bypass Graft Surgery
09:12

Surgical Swine Model of Chronic Cardiac Ischemia Treated by Off-Pump Coronary Artery Bypass Graft Surgery

Published on: March 27, 2018

A Turkish perspective on coronary artery bypass surgery and percutaneous coronary artery intervention in chronic

Güliz Kozdag1, Gökhan Ertas, Ender Emre

  • 1Department of Cardiology, Faculty of Medicine, Kocaeli University, Kocaeli, Turkey.

Angiology
|February 16, 2012
PubMed

Insights

Coronary revascularization, including bypass surgery and stenting, may improve outcomes for patients with systolic heart failure and coronary artery disease. These interventions show better prognosis compared to no revascularization in SHF patients.

Area of Science:

  • Cardiology
  • Cardiac Surgery
  • Interventional Cardiology

Background:

  • Systolic heart failure (SHF) poses significant mortality risks.
  • The comparative impact of coronary revascularization on clinical outcomes in SHF patients remains unclear.
  • Coronary artery disease (CAD) is a common comorbidity in SHF.

Purpose of the Study:

  • To evaluate the impact of coronary artery bypass graft (CABG) surgery and stent implantation on clinical outcomes in patients with systolic heart failure.
  • To compare outcomes between different revascularization strategies and no revascularization in SHF patients with CAD.

Main Methods:

  • Retrospective analysis of 637 patients hospitalized for decompensated SHF.
  • Categorization of patients based on the presence or absence of coronary artery disease (CAD).
  • Comparison of clinical outcomes, including cardiovascular mortality, among patients who underwent stenting alone, CABG surgery plus stenting, and no revascularization.

Main Results:

  • 35% of SHF patients died from cardiovascular causes during follow-up.
  • Patients with SHF and CAD who underwent stenting alone or CABG surgery plus stenting demonstrated a significantly better prognosis compared to those with CAD but no revascularization (P < .001 and P = .013, respectively).

Conclusions:

  • Coronary revascularization procedures, specifically stenting and combined CABG with stenting, may offer a survival benefit in patients with systolic heart failure and coronary artery disease.
  • These findings suggest that revascularization should be considered in the management of SHF patients with concomitant CAD.

More Related Videos

Surgical Porcine Model of Chronic Myocardial Ischemia Treated by Exosome-laden Collagen Patch and Off-pump Coronary Artery Bypass Graft05:25

Surgical Porcine Model of Chronic Myocardial Ischemia Treated by Exosome-laden Collagen Patch and Off-pump Coronary Artery Bypass Graft

Published on: September 15, 2023

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock07:39

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock

Published on: August 16, 2021

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...